A fitting tribute to a hero in the fight against the CHINA WUHAN VIRUS: Chinese social media tributes mark anniversary of whistleblower doctor's death | Philstar.com
A fitting tribute to a hero in the fight against the CHINA WUHAN VIRUS: Chinese social media tributes mark anniversary of whistleblower doctor's death | Philstar.com
Ano efficient sa america???? Pag nagkaside effect yan 2 to 5years from now eh tingnan mo ano mangyayari jan.
Sabi ko nga di ba, pag ang babae malaman ko nagpaturok eh hindi ko papatulan.
Patapos na america mo declining na pagisiip. Kita mo yung itsura nung bannon. Ganyan ang features ng legit white supremacist
"california is over, texas is next."
I also wonder how can you prove your disease if your doctor is private. Kukuha muna ng certificate sa private doctor mo bago pumunta sa government for vaccine?
Parang ang daming scenario na pwede magka gulo. I don't trust Duque will do a good job on handling this inoculation.
Sent from my Mi 9T Pro using Tsikot Forums mobile app
generally skeptical ako sa implementation coz incompetent mga tao sa gobyerno regardless of admin
lagi naman maganda ang mga press release pero pagdating sa implementation iba
over-promise under-deliver
Vaccine resistant variants... Di pa nila na test ung E484K, variant.
Oxford/AstraZeneca Covid-19 shot less effective against South Africa variant, study shows, Europe News & Top Stories - The Straits Times
British drugmaker AstraZeneca said on Saturday (Feb 6) its vaccine developed with the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of Covid-19, based on early data from a trial.
The study from South Africa's University of the Witwatersrand and Oxford University showed the vaccine had significantly reduced efficacy against the South African variant, according to a Financial Times report published earlier in the day.
Among coronavirus variants currently most concerning for scientists and public health experts are the so-called British, South African and Brazilian variants, which appear to spread more swiftly than others.
"In this small phase I/II trial, early data has shown limited efficacy against mild disease primarily due to the B.1.351 South African variant," an AstraZeneca spokesman said in response to the FT report.
The newspaper said none of the more than 2,000 trial participants had been hospitalised or died.
"However, we have not been able to properly ascertain its effect against severe disease and hospitalisation given that subjects were predominantly young healthy adults," the AstraZeneca spokesman said.
cathey!!!!!!
Bakit yung mga immigrants / american citizen kumukuha sa kadugo ko ng lianhua quingwen jiaonang
10packs. Mahal pa philpost 3thou papunta america not anymore united.
Meron ako yung per pack 48pcs. Nakatengga lang pang display.
the enemy of my enemy is my friend
China military donates Sinopharm vaccine to Pakistan military
![]()
Chronic Covid-19 and Convalescent Plasma May Boost Mutation Risk
British doctors who spent 102 days treating a cancer survivor for Covid-19 documented how the virus mutated after the man was treated with convalescent plasma.
The case study suggests the use of blood plasma donated from Covid-19 survivors may have put enough pressure on the virus to force it to evolve. The result: Less susceptibility to immune system antibodies that normally fight off infection, according to the report published Friday in the journal Nature.
While the convalescent plasma didn’t seem to harm the patient, it offered no clear benefit, said senior author Ravindra Gupta, a professor of clinical microbiology at the Cambridge Institute of Therapeutic Immunology and Infectious Disease. It should be used cautiously in people with chronic immune conditions, he said, preferably in clinical trials or carefully controlled settings.
The report also suggests that numerous mutations may be emerging among patients who have both compromised immune systems and chronic infections.
“When the virus has a chance to sit in one person for a long time and replicates for weeks and months, it learns how to fight the immune system,” Gupta said. It’s all about “pressure on the virus.”
British doctors who spent 102 days treating a cancer survivor for Covid-19 documented how the virus mutated after the man was treated with convalescent plasma.
The case study suggests the use of blood plasma donated from Covid-19 survivors may have put enough pressure on the virus to force it to evolve. The result: Less susceptibility to immune system antibodies that normally fight off infection, according to the report published Friday in the journal Nature.
While the convalescent plasma didn’t seem to harm the patient, it offered no clear benefit, said senior author Ravindra Gupta, a professor of clinical microbiology at the Cambridge Institute of Therapeutic Immunology and Infectious Disease. It should be used cautiously in people with chronic immune conditions, he said, preferably in clinical trials or carefully controlled settings.
The report also suggests that numerous mutations may be emerging among patients who have both compromised immune systems and chronic infections.
“When the virus has a chance to sit in one person for a long time and replicates for weeks and months, it learns how to fight the immune system,” Gupta said. It’s all about “pressure on the virus.”
![]()
Afghanistan gets first doses of Covid-19 vaccine from India
Naunahan tayo ng Afgahnistan! galing India.
Akala ko madami tayong mga Indian nationals dito.
Pumayag na kasi dapat ang gobyerno sa 5/6. hahaha Joke lang.
No faking illness to jump COVID vaccine line: Palace counts on doctors to issue certificates for persons with comorbidity – Manila Bulletin
Sent from my iPhone using Tapatalk
when a vaccine designed and tested in 2020 is no longer effective in 2021
South Africa suspends AstraZeneca vaccine drive
JOHANNESBURG (AP) — South Africa has suspended plans to inoculate its front-line health care workers with the Oxford-AstraZeneca vaccine after a small clinical trial suggested that it isn't effective in preventing mild to moderate illness from the variant dominant in the country.
South Africa received its first 1 million doses of the AstraZeneca vaccine last week and was expected to begin giving jabs to health care workers in mid-February. The disappointing early results indicate that an inoculation drive using the AstraZeneca vaccine may not be useful.
Even if half the world's population get vaccinated... A new mutation coming from the other half may wipe out any immunity they got...
Scientists in South Africa said on Sunday that a similar problem held for people who had been infected by earlier versions of the coronavirus: The immunity they acquired naturally did not appear to protect them from mild or moderate cases when they were reinfected by the variant, known as B.1.351.
Last edited by Monseratto; February 8th, 2021 at 10:37 AM.
Pero it offers protection ba from severe case? Kung oo then it's prudent ituloy pa rin bakuna
Sent from my iPhone using Tapatalk
baka nanghihinayang sa gastos.
they are probably waiting for a more perfect vaccine that covers all bases.
Last edited by dr. d; February 8th, 2021 at 10:01 AM.